- Ongoing, recruitingTherapeutic exploratory (Phase II)
A randomized, double-blind, placebo-controlled, Phase 2b trial with an open-label extension to determine the safety and efficacy of GH001 in patients with treatment-resistant depression.
This study is looking into a new treatment, GH001, for people whose depression hasn't responded to usual treatments. It aims to see if GH001 is safe and helps improve mood, compared to a dummy treatment. Participants will also have the option to continue treatment after the main study.
For: Treatment-resistant depression (TRD)Poland · Czechia · Germany - Ongoing, recruitingTherapeutic confirmatory (Phase III)
Prospective double-blind randomized comparative study of the use of methoxyflurane vs placebo in the management of pain in oral and dental emergencies in adults: METODO (METhoxyflurane in ODOntology)
This study looks at how well a medicine called methoxyflurane (Penthrox) helps adults with dental pain. It compares Penthrox to a dummy medicine to see if it reduces pain quickly during dental emergencies.
For: Dental careFrance